Abstract
In settings of resource constraint, an understanding of HIV drug resistance can guide antiretroviral therapy (ART) at switch to second-line therapy. To determine the prevalence of such HIV drug resistance mutations (HIV DRM), we used an in-house sequencing assay in the pol gene (protease and partial reverse transcriptase) in a cohort of patients suspected of failing a first-line regimen, which in Zambia comprises two nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and one non-nucleoside reverse transcriptase inhibitor (NNRTI). Our analysis cohort (n = 68) was referred to the University Teaching Hospital in Lusaka from November 2009 to October 2012. Median duration on first-line ART to suspected treatment failure was 3.2 years (IQR 1.7-4.7 years). The majority of patients (95%) harbored HIV-1 subtype C virus. Analysis of reverse transcriptase revealed M184V (88%), K103N/S (32%), and Y181C/I/V (41%) DRMs, with the latter conferring reduced susceptibility to the salvage therapy candidates etravirine and rilpivirine. Three patients (5%) had major protease inhibitor (PI) resistance mutations: all three had the V82A mutation, and one patient (Clade J virus) had a concurrent M46I, Q58E, and L76V DRM. HIV-1 genotyping re...Continue Reading
References
Nov 3, 1994·The New England Journal of Medicine·E M ConnorR L Jacobson
Apr 25, 2001·The Journal of Infectious Diseases·M M BerreyL Corey
Sep 8, 2001·AIDS·P R HarriganB A Larder
Jul 20, 2002·Lancet·Matthias EggerUNKNOWN ART Cohort Collaboration
Jul 23, 2002·Journal of Virology·Jianming TangUNKNOWN Zambia-UAB HIV Research Project
Feb 19, 2009·International Journal of Epidemiology·Benjamin H ChiJeffrey S A Stringer
Nov 18, 2009·Journal of Virological Methods·Carole L WallisWendy Stevens
Dec 17, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Benjamin H ChiJeffrey S A Stringer
Jul 14, 2010·AIDS Research and Human Retroviruses·Sandra GonzalezCharles Wood
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Jan 25, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Nitika Pant PaiJorge Martinez Cajas
Mar 9, 2012·Patient Preference and Adherence·Teresa L KaufE Anne Davis
Jul 10, 2012·Patient Education and Counseling·Alexis M RothThomas S Inui
Jul 14, 2012·Molecular Biology International·Mark A Wainberg, Bluma G Brenner
Jul 26, 2012·Lancet·Ravindra K GuptaSilvia Bertagnolio
Dec 21, 2012·ACS Chemical Biology·Jennifer E Foulkes-MurzyckiCelia A Schiffer
Aug 9, 2013·AIDS Research and Human Retroviruses·Michael J VinikoorBenjamin H Chi
Mar 29, 2014·Journal of Virological Methods·Lillian SeuM Bradford Guffey
May 6, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carole L WallisUNKNOWN A5230 team
Citations
Aug 18, 2020·PloS One·Sam MitiJulie A Denison
Oct 6, 2016·Immunologic Research·Ronald Moura RodriguesSergio Crovella
Jun 15, 2017·Health Research Policy and Systems·Tendai MunthaliJim Todd
Aug 24, 2018·The Journal of Antimicrobial Chemotherapy·Negussie TaffaElliot Raizes
Nov 18, 2020·AIDS Research and Human Retroviruses·Urban Haankuku, Peter Njuho